Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_assertion type Assertion NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_head.
- NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_assertion description "[Aberrant activation of FGFR3 via overexpression or mutation is a frequent feature of bladder cancer; however, its molecular and cellular consequences and functional relevance to carcinogenesis are not well understood.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_provenance.
- NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_assertion evidence source_evidence_literature NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_provenance.
- NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_assertion SIO_000772 23019225 NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_provenance.
- NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_assertion wasDerivedFrom befree-20150227 NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_provenance.
- NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_assertion wasGeneratedBy ECO_0000203 NP401157.RAaV07UJ2CXBU-8xTlPmfzfm4Doxyrlru9-HKj2GZYoW0130_provenance.